Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Diclofenac Market Research Report 2019-2025

Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Diclofenac Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Osteoarthritis
      • 1.3.3 Ankylosing Spondylitis
      • 1.3.4 Dysmenorrhea
      • 1.3.5 Rheumatoid Arthritis
      • 1.3.6 Migraine
      • 1.3.7 Pain
      • 1.3.8 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Diclofenac Market Share by Application (2019-2025)
      • 1.4.2 Oral
      • 1.4.3 Parenteral
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Diclofenac Market Size
      • 2.1.1 Global Diclofenac Revenue 2014-2025
      • 2.1.2 Global Diclofenac Sales 2014-2025
    • 2.2 Diclofenac Growth Rate by Regions
      • 2.2.1 Global Diclofenac Sales by Regions 2014-2019
      • 2.2.2 Global Diclofenac Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Diclofenac Sales by Manufacturers
      • 3.1.1 Diclofenac Sales by Manufacturers 2014-2019
      • 3.1.2 Diclofenac Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Diclofenac Revenue by Manufacturers (2014-2019)
      • 3.2.2 Diclofenac Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Diclofenac Market Concentration Ratio (CR5 and HHI)
    • 3.3 Diclofenac Price by Manufacturers
    • 3.4 Key Manufacturers Diclofenac Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Diclofenac Market
    • 3.6 Key Manufacturers Diclofenac Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Osteoarthritis Sales and Revenue (2014-2019)
      • 4.1.2 Ankylosing Spondylitis Sales and Revenue (2014-2019)
      • 4.1.3 Dysmenorrhea Sales and Revenue (2014-2019)
      • 4.1.4 Rheumatoid Arthritis Sales and Revenue (2014-2019)
      • 4.1.5 Migraine Sales and Revenue (2014-2019)
      • 4.1.6 Pain Sales and Revenue (2014-2019)
      • 4.1.7 Others Sales and Revenue (2014-2019)
    • 4.2 Global Diclofenac Sales Market Share by Type
    • 4.3 Global Diclofenac Revenue Market Share by Type
    • 4.4 Diclofenac Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Diclofenac Sales by Application

    6 United States

    • 6.1 United States Diclofenac Breakdown Data by Company
    • 6.2 United States Diclofenac Breakdown Data by Type
    • 6.3 United States Diclofenac Breakdown Data by Application

    7 European Union

    • 7.1 European Union Diclofenac Breakdown Data by Company
    • 7.2 European Union Diclofenac Breakdown Data by Type
    • 7.3 European Union Diclofenac Breakdown Data by Application

    8 China

    • 8.1 China Diclofenac Breakdown Data by Company
    • 8.2 China Diclofenac Breakdown Data by Type
    • 8.3 China Diclofenac Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Diclofenac Breakdown Data by Company
    • 9.2 Rest of World Diclofenac Breakdown Data by Type
    • 9.3 Rest of World Diclofenac Breakdown Data by Application
    • 9.4 Rest of World Diclofenac Breakdown Data by Countries
      • 9.4.1 Rest of World Diclofenac Sales by Countries
      • 9.4.2 Rest of World Diclofenac Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Auro Laboratories
      • 10.1.1 Auro Laboratories Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Diclofenac
      • 10.1.4 Diclofenac Product Introduction
      • 10.1.5 Auro Laboratories Recent Development
    • 10.2 Henan Dongtai
      • 10.2.1 Henan Dongtai Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Diclofenac
      • 10.2.4 Diclofenac Product Introduction
      • 10.2.5 Henan Dongtai Recent Development
    • 10.3 Bayer
      • 10.3.1 Bayer Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Diclofenac
      • 10.3.4 Diclofenac Product Introduction
      • 10.3.5 Bayer Recent Development
    • 10.4 Pfizer
      • 10.4.1 Pfizer Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Diclofenac
      • 10.4.4 Diclofenac Product Introduction
      • 10.4.5 Pfizer Recent Development
    • 10.5 Hunan Warrant
      • 10.5.1 Hunan Warrant Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Diclofenac
      • 10.5.4 Diclofenac Product Introduction
      • 10.5.5 Hunan Warrant Recent Development
    • 10.6 Novartis
      • 10.6.1 Novartis Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Diclofenac
      • 10.6.4 Diclofenac Product Introduction
      • 10.6.5 Novartis Recent Development
    • 10.7 Simcere
      • 10.7.1 Simcere Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Diclofenac
      • 10.7.4 Diclofenac Product Introduction
      • 10.7.5 Simcere Recent Development
    • 10.8 Merck
      • 10.8.1 Merck Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Diclofenac
      • 10.8.4 Diclofenac Product Introduction
      • 10.8.5 Merck Recent Development
    • 10.9 Istituto Biochimico
      • 10.9.1 Istituto Biochimico Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Diclofenac
      • 10.9.4 Diclofenac Product Introduction
      • 10.9.5 Istituto Biochimico Recent Development
    • 10.10 Metrix Healthcare
      • 10.10.1 Metrix Healthcare Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Diclofenac
      • 10.10.4 Diclofenac Product Introduction
      • 10.10.5 Metrix Healthcare Recent Development
    • 10.11 Aarti
    • 10.12 Kairav Chemicals
    • 10.13 Nipa Pharmaceuticals

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Diclofenac Sales Channels
      • 11.2.2 Diclofenac Distributors
    • 11.3 Diclofenac Customers

    12 Market Forecast

    • 12.1 Global Diclofenac Sales and Revenue Forecast 2019-2025
    • 12.2 Global Diclofenac Sales Forecast by Type
    • 12.3 Global Diclofenac Sales Forecast by Application
    • 12.4 Diclofenac Forecast by Regions
      • 12.4.1 Global Diclofenac Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Diclofenac Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Diclofenac is a non-steroidal anti-inflammatory drug (NSAID) that is mainly employed to treat mild-to-moderate pain & reduces pain, inflammation, swelling, and stiffness. It is supplied as or contained in medications under a variety of trade names.
      This drug is applicable for inflammatory disorders such as arthritis, rheumatoid arthritis, dermatomyositis, osteoarthritis, dental pain, spondylarthritis, and gout attacks.
      In 2019, the market size of Diclofenac is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Diclofenac.

      This report studies the global market size of Diclofenac, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Diclofenac sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Auro Laboratories
      Henan Dongtai
      Bayer
      Pfizer
      Hunan Warrant
      Novartis
      Simcere
      Merck
      Istituto Biochimico
      Metrix Healthcare
      Aarti
      Kairav Chemicals
      Nipa Pharmaceuticals

      Market Segment by Product Type
      Osteoarthritis
      Ankylosing Spondylitis
      Dysmenorrhea
      Rheumatoid Arthritis
      Migraine
      Pain
      Others

      Market Segment by Application
      Oral
      Parenteral

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Diclofenac status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Diclofenac manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Diclofenac are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now